Clinical Trial Update: Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a triple treatment for detachment of the retinal pigment epithelium secondary to polypoidal choroidal vasculopathy has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Neovascularization
• Polypoidal Choroidal Vasculopathy
• Retinal Pigment Epithelial Detachment

Snippet

Sponsor: Federal University of São Paulo | Conditions: Choroidal Neovascularization, Retinal Pigment Epithelial Detachment | Phase 4 | Status: WITHDRAWN